Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

Tumor necrosis factor-inhibitor associated dermatomyositis - PMC

Dermatomyositis is an autoimmune disease of unknown etiology characterized by inflammation of the skin and muscles. Several medications have been implicated in ...

Tumor necrosis factor inhibitor-associated dermatomyositis - PubMed

Tumor necrosis factor inhibitors have been associated with the onset of a number of autoimmune disorders, most commonly vasculitis and a lupuslike syndrome.

Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a ...

We describe the first case of anti-TNF–associated DM without muscle involvement presenting in an adult patient with a history of arthritis since childhood.

Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

We report 4 cases of dermatomyositis that developed or were exac- erbated by exposure to the TNF inhibitors etanercept and adalimumab. Observation: Four ...

Tumor Necrosis Factor-α in Inflammatory Myopathies

TNF-α may have a role in the pathogenesis of the myositis and has emerged as a possible therapeutic target.

Tumor necrosis factor inhibitor-associated dermatomyositis

Conclusions: Tumor necrosis factor inhibitors have been associated with the onset of a number of autoimmune disorders, most commonly vasculitis and a lupuslike ...

Three cases of anti-TNF induced myositis and literature review

TNF inhibitors are important drugs used in the treatment of autoinflammatory diseases. They can rarely induce the development of myositis besides the known ...

Drug-Induced Dermatomyositis Due to Tumor Necrosis Factor ...

TNF inhibitors are valuable against inflammatory disease, but reports link their use to dermatomyositis in some patients. Dermatomyositis (DM) ...

Dermatomyositis–lupuslike syndrome overlap under treatment with ...

The most common TNF-α inhibitor associated with dermatomyositis is etanercept, followed by adalimumab and infliximab. The interval between TNF-α ...

Dermatomyositis associated with anti–tumor necrosis factor therapy ...

To the Editor: Anti–tumor necrosis factor (a-TNF) agents have become a common treatment for many different autoimmune diseases. Due to conflicting effects ...

Anti-Tumor Necrosis Factor Inhibitor Therapy-induced ...

Cases of myopathies associated with anti-TNF inhibitors have been described. ... There are 5 other cases of DM treated with etanercept; these ...

New Onset of Juvenile Dermatomyositis During Tumor Necrosis

Tumour necrosis factor inhibitor (TNF-inhibitor) treatment may be useful for the treatment of patients with refractory juvenile dermatomyositis (JDM).[1] ...

Dermatomyositis associated with anti-tumor necrosis factor therapy ...

To the Editor: Antietumor necrosis factor (a-TNF) agents have become a common treatment for many different autoimmune diseases. Due to conflicting effects ...

Successful Treatment of Dermatomyositis and Polymyositis with Anti ...

Tumor necrosis factor α neutralization seems a rational therapy for myositis because this proinflammatory cytokine has been implicated in ...

Dermatomyositis During Adalimumab Therapy for Rheumatoid Arthritis

TNF-α blockers inhibit the cytotoxic T-lymphocyte response that would normally suppress the autoreactive B-cell response, promoting humoral ...

Possible role for tumour necrosis factor inhibitors in the treatment of ...

Results: 8 patients with dermatomyositis or polymyositis who were treated with TNF inhibitors as adjunct treatment were identified. The mean (SD) duration of ...

New Onset of Dermatomyositis/Polymyositis during Anti‐TNF‐α ...

The emergence of DM/PM and antisynthetase syndrome seem to be associated with the use of anti-TNF-α agents, especially in patients with chronic inflammatory ...

Anti tumor necrosis factor induced focal myositis - Sage Journals

Tumour necrosis factor inhibitors can induce various autoantibodies and be associated with autoimmune diseases including focal myositis. A differential ...

Three cases of anti-TNF induced myositis and literature review

Anti-tumor necrosis factor drugs are frequently preferred in the treatment of rheumatologic diseases and other inflammatory diseases. The development of ...

Tumour necrosis factor inhibitor-induced myositis in a patient with ...

Tumor necrosis factor inhibitor-associated dermatomyositis. Arch. Dermatol. 2010;146(7):780–784. [13] Ishikawa Y, Yukawa N, Ohmura K, et al. Etanercept ...